Sign in
4

Changes in Ownership

Atrium Therapeutics, Inc. Filed Acc 0001193125-26-397951

Director gave up 126,418 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Boyce Sarah Director 2026-09-18 Shares withheld for taxes −126,418 $8.95 $1,131,441 138,668 D: show line 1 in the form
Loading xslF345X06/ownership.xml…